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The aerial parts of Artemisia frigida Willd. are used to treat joint swelling, renal heat,
abnormal menstruation, and sore carbuncle. The anti-inflammatory effects of A. frigida
have been well-known in folk medicine, suggesting that components extracted from
A. frigida could potentially treat inflammatory disease. With the aim of discovering
bioactive compounds, in this study, we extracted total flavonoids from the aerial parts of
A. frigida and investigated their anti-inflammatory effects against inflammation induced by
carrageenan and egg albumin in rats. At the doses studied, total flavonoids (100 mg/kg,
200 mg/kg, and 400 mg/kg) and some isolated compounds (30 mg/kg) showed significant
and dose-dependent anti-inflammatory effects. According to the high-performance liquid
chromatography analysis of the total flavonoids from A. frigida, there are five major
compounds, namely, 5-hydroxy-30,40-dimethoxy-7-O-b-D-glucuronide (F1), 5-hydroxy-
30,40,50-trimethoxy-7-O-b-D-glucuronide (F2), 5,7,30-trihydroxy-6,40-dimethoxyflavone (F3),
5,30-dihydroxy-6,7,40-trimethoxyflavone (F4), and 5,30-dihydroxy-3,6,7,40-tetramethoxy-
flavone (F5), which may explain the anti-inflammatory activity.
Copyright © 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Inflammation is a pathophysiological response of living tis-
sues to injuries that leads to the local accumulation of plas-
matic fluid and blood cells, which involves a complex
sequence of biochemical events closely associated with thel Mongolian Medicine, In
ng).
inistration, Taiwan. Publis
/licenses/by-nc-nd/4.0/).pathogenesis of various diseases such as rheumatoid arthritis,
osteoarthritis, ankylosing spondylitis, acute gout, and
migraine [1e3].
Nowadays, although the synthetic anti-inflammatory
drugs are dominating the market, the element of toxicity
from these drugs cannot be ignored. Many drugs [both
nonsteroidal anti-inflammatory drugs (NSAIDs) andner Mongolia University for Nationalities, No. 536 Hulinhe District,
hed by Elsevier Taiwan LLC. This is an open access article under the CC
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 3 8 5e3 9 1386corticosteroids] have been developed but their safety profile
studies have shown that none of them is clearly safe.
Because of adverse reactions of synthetic medicines, that is,
causing gastrointestinal irritation and reappearance of
symptoms after discontinuation, herbal medicines have
made a comeback to improve our basic health needs. Many
plants and herbs such as ginger, turmeric, and olive oil have
been shown to exhibit potent anti-inflammatory effects [4].
Currently available drugs such as opiates and NSAIDs are
not useful in all cases due to their adverse effects. In this
regard, new compounds with improved pain management
capacity and fewer side effects are searched every nook and
corner of the world, which can serve as alternatives to
NSAIDs and opiates. There is an increasing focus on evalu-
ating the efficacy of plant-based drugs used in the tradi-
tional medicine because they are cheap and have little or no
side effects [5,6].
Artemisia frigida is a member of the Compositae family and
is distributed throughout Inner Mongolia, occupying 10.38% of
its Steppe [7]. It is widely used in Mongolian traditional med-
icine for treatment of diverse diseases, especially for arthritis
and rheumatoid [8]. In our previous studies, flavonoids [9e14],
sesquiterpene lactone glycosides [15], and coumarins [16]
were isolated from this plant.
Flavonoids are a class of secondary metabolites generally
located in plant leaves, flowers, and stems [17]. These com-
pounds are not only present in plants as constitutive agents
but are also accumulated in plant tissues in response to mi-
crobial attack [18,19]. During the recent years, flavonoids have
been isolated frommany plants and are demonstrated to have
significant pharmacological activities, such as anti-
inflammatory, antioxidant, and hepatoprotective effects
[20,21]. However, until recently, there have been few studies
about the pharmacological effects ofA. frigida. With the aim of
discovering bioactive compounds, in this study, we extracted
total flavonoids from the aerial parts of A. frigida and inves-
tigated their anti-inflammatory effects against inflammation
induced by carrageenan and egg albumin in rats. We also
describe the anti-inflammatory activity and the high-
performance liquid chromatography (HPLC) analysis of the
total flavonoids extracted from the aerial parts of A. frigida.2. Methods
2.1. Plant material
The aerial parts of A. frigida were collected from Tongliao,
Inner Mongolia of China, in July 2014, and identified by Pro-
fessor Buhebateer (Inner Mongolia University for National-
ities). A voucher (No. 20140714) has been deposited in the
School of Traditional Mongolian Medicine of Inner Mongolia
University for Nationalities.
2.2. Animals
Male Wistar rats (200e300 g) were provided by Changchun
Yisheng Laboratory Animal Technology Co., Ltd. (Changchun,
China). The rats were maintained under standard animal
housing conditions (25 ± 5C, 40e70% relative humidity, 12-hour light/dark cycle) and provided with standard laboratory
food [rat sterile granulated feed, product executive standard:
GB14924e2001, license: SCXKe(JI) 2010e0001] and water ad
libitum. They were fasted for 24 hours before a test.
2.3. Preparation of total flavonoids from A. frigida
The air-dried aerial parts of A. frigida (2 kg) were crushed and
extracted two times with 75% ethanol in a 50 L solvent volume
for 6 hours under reflux. The ethanol solution was vacuum
evaporated at 60C. Approximately 860 g of the residual
ethanol was obtained. The extract was then dissolved in
300 mL of water and added onto the D-101 macroporous
adsorption resin chromatographic column (500 g). After
eluting with 5 L ethanolewater (20:80), 10 L ethanolewater
(85:15) eluate was concentrated in vacuum to dryness. The
residue (580 g) was stored in a refrigerator (0e4C) until further
use.
2.4. HPLC isolation of total flavonoids and nuclear
magnetic resonance identification of HPLC fractions
The liquid chromatography (LC) system consisted of an LC-
20AT pump (Shimadzu, Japan), Shimadzu SPD-20A detector,
and Shimadzu CBM-20A software for data processing. A so-
lution of 35% methanol was passed through an HPLC colum-
ndEZ0566 (250 mm  20 mm, 5 mm). The column temperature
was maintained constant at 30C. The flow rate was 5mL/min
and the injection volume was 200 mL. Approximately 1.5 g of
the dried total flavonoids was ground into a powder form,
accurately weighed, soaked with 50 mL water and acetonitrile
solution (70:30, v/v) for 60 minutes at room temperature, and
then sonicated for 20 minutes. The solution was filtered
through a 0.45-mm membrane filter before LC isolation, and
then separated by semipreparative HPLC to yield 172 mg of F1
at 99.0% purity, 164 mg of F2 at 98.5% purity, 102 mg of F3 at
96.3% purity, 91 mg of F4 at 95.2% purity, and 88 mg of F5 at
94.8% purity from 1.50 g of the total flavonoids. The purity of
Compounds F1eF5 was determined by normalization of the
peak areas detected by HPLC.
The structures of Compounds F1eF5 were identified by
nuclear magnetic resonance (NMR). NMR spectra were
measured on a Bruker Avance III-500 NMR spectrometer using
tetramethylsilane as the internal reference, and chemical
shifts are expressed in d (ppm).
2.5. Anti-inflammatory activity on carrageenan-induced
paw edema
The total flavonoids and compounds (F1eF5) isolated from the
aerial parts of A. frigida were investigated for their anti-
inflammatory effects against inflammation induced by
carrageenan and egg albumin in rats and their inhibitory ef-
fects on granuloma induced by cotton pellet in rats according
to the method described previously [22]. The animals were
divided into 10 groups of eight rats. The negative control group
received distilled water (0.5 mL/kg, p.o.), the positive control
group received luteolin (30 mg/kg, p.o.), and the test groups
received the total flavonoids at doses of 100 mg/kg p.o.,
200 mg/kg p.o., and 400 mg/kg p.o. and compounds F1eF5 at
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tric plethysmometer 7140 (Ugo Basile, Monvalle VA, Italy).
Carrageenan 2.5% (0.05 mL) was subcutaneously injected into
the plantar surface of the rat's left hind paw 1 hour after the
oral administration of drugs to induce a progressive swelling
of the paw. The paw volume, up to the tibiotarsal articulation,
was measured at 0 hours (before carrageenan injection) and
1 hour, 3 hours, 5 hours, and 10 hours later.2.6. Egg albumin-induced inflammation in rats
To test the effects of total flavonoids and compounds (F1eF5)
isolated from the aerial parts of A. frigida against inflamma-
tion, the method described by Ghisalberti [23] was adopted. In
brief, rats were grouped into ten. The negative control group
received distilled water (10 mL/kg, p.o.), the positive control
group received luteolin (30 mg/kg, p.o.), and the test groups
received the total flavonoids at the doses of 100 mg/kg p.o.,
200 mg/kg p.o., and 400 mg/kg p.o. and compounds F1eF5 at
doses of 30 mg/kg p.o. All the animals were injected with
0.1 mL of fresh egg albumin subcutaneously into the left hind
paw 30 minutes after the administration of aforementioned
compounds/drug. The volume of paw edema in each rat was
measured using a digital plethysmometer (LE 7500) prior to
and 60 minutes after the albumin injection and at every
60 minutes up to 240 minutes.2.7. Acute toxicity
For the assessment of acute toxicity, Wistar rats, male and
female, were divided into groups of 10 animals. The total fla-
vonoids were administered orally to rats in Groups 1e6 at
doses of 100 mg/kg, 500 mg/kg, 1000 mg/kg, 1500 mg/kg,
2000 mg/kg, and 3000 mg/kg, respectively. The control group
received distilled water (10 mL/kg, p.o.). The mortality rate
within the 72-hour period was determined and the lethal dose
50% (LD50) was estimated according to the method described
previously [24].2.8. Statistical analysis
Data are presented as means ± standard error. Statistical an-
alyses were carried out using Student t-test. A p value less
than 0.05 is considered significant.Fig. 1 e High-performance liquid chromatography chroma3. Results and discussion
3.1. HPLC isolation of total flavonoids and NMR
identification of compounds F1eF5
The HPLC assay method developed in this study was applied
to the isolation of total flavonoids from A. frigida. The HPLC
chromatogram is shown in Fig. 1, which mainly contains five
compounds (F1eF5). The structures of compounds F1eF5were
identified by spectroscopic methods including 1H NMR (Table
1), 13C NMR (Table 2), and by comparing the data obtainedwith
those reported in the literature [9e14].
Compound F1 was obtained as a yellow powder. In the 1H
NMR spectrum, the signals of five aromatic protons at d 6.42
(1H, d, J ¼ 2.0 Hz, H-6), 6.95 (1H, d, J ¼ 2.0 Hz, H-6), 7.63 (1H, d,
J ¼ 2.0 Hz, H-20), 6.98 (1H, d, J ¼ 8.0 Hz, H-50), and 7.61 (1H, dd,
J ¼ 8.0, 2.0 Hz, H-60) indicated the presence of an AB system
and an ABC system, and a characteristic signal of H-3 of a
flavone at d 6.93 (1H, s), which was confirmed based on the
heteronuclear multiple-bond correlations (HMBC) from d 6.93
(1H, s) to dC 182.5 (C-4), 164.2 (C-2), 105.3 (C-10), and 121.3 (C-10).
Moreover, the HMBC from CH3Oe (d 3.93) to C-40 and from
CH3Oe (d 3.91) to C-30 indicated that the methoxy groups were
attached to C-40 and C-30, respectively.
The 13C NMR spectrum of F1 showed the presence of six
carbon signals except for the glycone carbons at d 102.2, 73.5,
74.0, 71.8, 76.5, and 171.3, which belong to a b-D-glucuronyl
group based on the coupling constant of the anomeric protons
at d 5.09 (1H, d, J¼ 7.0Hz). In addition, theHMBC from d 5.09 (1H,
d, J ¼ 7.0 Hz) to C-7 (d 163.0) indicated that the b-D-glucuronyl
groupwas attached to C-7. Compound F1was thus established
as 5-hydroxy-30,40-dimethoxy-7-O-b-D-glucuronide.
Compound F2 was obtained as a yellow powder. 1H and
13C NMR spectral data of F2 were similar to those of F1,
except for the B ring. In particular, the ABX system in F1 was
substituted by the A2 system in F2, and this was confirmed
by the proton signals at d 7.35 (2H, s, H-20, H-60) and at d 3.89
(6H, s) and 3.91 (3H, s). The HMBC from the anomeric pro-
tons at d 5.11 to C-7 revealed that the sugar moiety was
linked to the C-7 of the aglycone. The anomeric configura-
tion in the sugar moiety was determined as b according to
the coupling constant (7.0 Hz). Therefore, the structure of F2
was elucidated as 5-hydroxy-30,40,50-trimethoxy-7-O-b-D-
glucuronide.togram of the total flavonoids from Artemisia frigida.
Table 1 e 1H-NMR (500 MHz, J in Hz) spectral data for compounds F1eF5 in DMSO-d6.
No. F1 F2 F3 F4 F5
2 d d d d d
3 6.93 (s) 7.04 (s) 6.56 (s) 6.61 (s) d
4 d d d d d
5 d d d d d
6 6.42 (d, 2.0) 6.44 (d, 2.0) d d d
7 d d d d d
8 6.95 (d, 2.0) 6.92 (d, 2.0) 6.91 (s) 6.93 (s) 6.93 (s)
9 d d d d d
10 d d d d d
10 d d d d d
20 7.63 (d, 2.0) 7.35 (s) 7.52 (d, 2.0) 7.60 (d, 2.0) 7.65 (d, 2.0)
30 d d d d d
40 d d d d d
50 6.98 (d, 8.0) d 6.95 (d, 8.0) 6.94 (d, 8.0) 6.97 (d, 8.0)
60 7.61 (d, 8.0, 2.0) 7.35 (s) 7.56 (dd, 8.0, 2.0) 7.62 (dd, 8.0, 2.0) 7.61 (dd, 8.0, 2.0)
100 5.09 (d, 7.0) 5.11 (d, 7.0)
200 3.24 (m) 3.28 (m)
300 3.25 (m) 3.32 (m)
400 3.12 (m) 3.18 (m)
500 3.63 (m) 3.65 (m)
600 d d
OCH3 3.93 (s)
3.91 (s)
3.89 (s)
3.91 (s)
3.89 (s)
3.88 (s)
3.76 (s)
3.94 (s)
3.90 (s)
3.74 (s)
3.93 (s)
3.91 (s)
3.89 (s)
3.78 (s)
DMSO-d6 ¼ dimethyl sulfoxide-d6; NMR ¼ nuclear magnetic resonance.
Table 2e 13C-NMR (125MHz) spectral data for compounds
F1eF5 in DMSO-d6.
No. F1 F2 F3 F4 F5
2 164.2 164.2 164.3 164.0 151.2
3 103.5 103.9 103.1 103.2 137.1
4 182.5 182.0 181.5 182.2 178.3
5 161.0 161.2 152.4 152.7 151.9
6 99.0 99.5 130.8 131.8 131.2
7 163.0 163.1 156.1 152.5 158.6
8 96.1 95.2 90.8 91.7 91.8
9 157.18 156.8 153.5 158.7 155.8
10 105.3 105.1 101.6 105.2 105.6
10 121.3 120.2 121.1 121.5 122.4
20 115.8 104.5 112.7 115.8 115.6
30 148.6 148.2 145.9 148.1 147.8
40 149.5 140.3 149.7 150.9 150.2
50 111.0 148.3 115.7 110.3 112.3
60 119.8 104.5 120.4 120.5 120.6
100 102.2 103.1
200 73.5 73.1
300 74.0 73.8
400 71.8 72.0
500 76.5 76.6
600 171.3 172.1
OCH3 56.3 56.5 (2) 56.1 56.4 56.3
56.1 59.6 55.0 56.1 56.2
55.1 55.8
55.2
DMSO-d6¼dimethylsulfoxide-d6;NMR¼nuclearmagnetic resonance.
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NMR spectrum, the signals of four aromatic protons at d 7.52
(1H, d, J ¼ 2.0 Hz), 6.95 (1H, d, J ¼ 8.0 Hz), and 7.56 (1H, dd,
J ¼ 8.0, 2.0 Hz) indicated the presence of an ABC system, and a
characteristic signal of H-3 of a flavone at d 6.56 (1H, s), which
was confirmed according to the HMBC from d 6.56 (H-3) to
d 181.5 (C-4), 164.3 (C-2), 106.1 (C-10), and 121.1 (C-1). The
remaining aromatic signal at d 6.91 (1H, s) was assigned to H-8
based on its correlations with dC 130.8 (C-6) and 101.6 (C-10).
The 13C NMR spectrum of F3 also showed the presence of 15
carbon signals of a flavone except for the twomethoxy groups
at d 164.3 (C-2), 103.1 (C-3), 181.5 (C-4), 152.4 (C-5), 130.8 (C-6),
156.1 (C-7), 90.8 (C-8), 153.5 (C-9), 101.6 (C-10), 121.1 (C-10), 112.7
(C-20), 145.9 (C-30), 149.7 (C-40), 115.7 (C-50), and 120.4 (C-60). In
addition, the HMBC from d 3.76 (3H, s) to C-6 (d 130.8) and from
3.88 (3H, s) to C-40 (d 149.5) indicated that the two methoxy
groupswere attached to C-6 and C-40, respectively. Compound
F3 was thus established as 5,7,30-trihydroxy-6,40-
dimethoxyflavone.
Compound F4 was obtained as a yellow powder. 1H and 13C
NMR spectral data of F4 were similar to those of F3, except for
the appearance of one additional CH3Oe. The HMBC from
CH3Oe (d 3.74) to C-6, from CH3Oe (d 3.90) to C-40, and from
CH3Oe (d 3.94) to C-7 indicated that the methoxy groups were
attached to C-6, C-40, and C-7, respectively. Therefore, the
structure of F4 was elucidated as 5,30-dihydroxy-6,7,40-
trimethoxyflavone.
Compound F4 was obtained as a yellow powder. 1H and 13C
NMR spectral data of F5were also similar to those of F4, except
for the appearance of one additional CH3Oe. The HMBC from
CH3Oe (d 3.78) to C-6, from CH3Oe (d 3.89) to C-40, from CH3Oe
(d 3.93) to C-7, and fromCH3Oe (d 3.91) to C-3 indicated that themethoxy groups were attached to C-6, C-40, C-7, and C-3,
respectively. Therefore, the structure of F5 was elucidated as
5,30-dihydroxy-3,6,7,40-tetramethoxyflavone.
Table 3 e Anti-inflammatory effects of the total flavonoids and compounds isolated from Artemisia frigida on carrageenan-
induced hind paw edema.
Treatment Dose (p.o., mg/kg) Volume of edema (mL) by hour
0 1 3 5 10
Distilled water 1.13 ± 0.13 1.17 ± 0.15 1.86 ± 0.18 2.58 ± 0.27 2.71 ± 0.30
Luteolin 30 1.10 ± 0.10 1.18 ± 0.23 1.61 ± 0.24* 1.89 ± 0.30** 1.89 ± 0.27***
Total flavonoids 100 1.08 ± 0.15 1.16 ± 0.44 1.89 ± 0.26 2.25 ± 0.20* 2.09 ± 0.16**
Total flavonoids 200 1.15 ± 0.16 1.23 ± 0.14 1.59 ± 0.25* 2.06 ± 0.21** 1.49 ± 0.11***
Total flavonoids 400 1.18 ± 0.20 0.96 ± 0.18* 1.48 ± 0.15** 1.55 ± 0.39*** 1.84 ± 0.29***
F1 30 1.07 ± 0.18 0.98 ± 0.14* 1.55 ± 0.15** 1.91 ± 0.09*** 2.16 ± 0.19**
F2 30 1.01 ± 0.17 0.82 ± 0.38* 1.39 ± 0.26** 1.82 ± 0.11*** 2.25 ± 0.13**
F3 30 1.10 ± 0.09 0.91 ± 0.15* 1.62 ± 0.20* 1.54 ± 0.39*** 2.30 ± 0.12**
F4 30 1.12 ± 0.17 1.13 ± 0.29 1.56 ± 0.20* 2.01 ± 0.17** 1.94 ± 0.31**
F5 30 1.14 ± 0.11 1.15 ± 0.30 1.55 ± 0.31* 2.04 ± 0.21** 1.75 ± 0.48**
Results are expressed as means ± SD; n ¼ 8.
*p < 0.05 compared with negative control.
**p < 0.01 compared with negative control.
***p < 0.001 compared with negative control.
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against inflammation induced by carrageenan and egg albu-
min in rats in the following experiments.
3.2. Acute toxicity
No mortality was observed in the groups of rats treated with
the total flavonoids. The LD50 values for the total flavonoids is
more than 3000 mg/kg.
3.3. Anti-inflammatory activity
The anti-inflammatory activities of the total flavonoids and
compounds (F1eF5) isolated from the aerial parts of A. frigida
have been evaluated using carrageenan and egg albumin in
rats and the results are presented in Tables 3 and 4. The total
flavonoids showed an anti-inflammatory effect at 100 mg/kg,
200 mg/kg, and 400 mg/kg (doses), which were observable at
10 hours (p < 0.01), 5 hours (p < 0.01), and 3 hours (p < 0.01),
respectively (Table 3). The highest dose of total flavonoids
showed significant anti-inflammatory activity, which wereTable 4 e Effects of the total flavonoids and some isolated com
Treatment Dose (p.o., mg/kg)
0
Distilled water 1.10 ± 0.10 1.3
Luteolin 30 1.09 ± 0.12 1.2
Total flavonoids 100 1.12 ± 0.09 1.2
Total flavonoids 200 1.08 ± 0.11 1.1
Total flavonoids 400 1.07 ± 0.08 1.0
F1 30 1.11 ± 0.13 1.1
F2 30 1.08 ± 0.08 1.2
F3 30 1.05 ± 0.17 1.0
F4 30 1.18 ± 0.20 1.2
F5 30 1.19 ± 0.14 1.3
Results are expressed as means ± SD; n ¼ 8.
*p < 0.05 compared with negative control.
**p < 0.01 compared with negative control.
***p < 0.001 compared with negative control.more than that of luteolin; however, the activity of the me-
dium dose is similar to that of luteolin. The total flavonoids
caused a significant and dose-dependent inhibition of
increase in paw edema (Table 4). The highest dose of total
flavonoids had higher anti-inflammatory effects than that of
luteolin, whereas the activity of the lower dose is less than
that of luteolin.
Compounds F1eF5 exhibited a significant suppression of
inflammation in rats compared with the control. Compound
F5 showed significant anti-inflammatory activity, which was
also higher than that exhibited by luteolin on egg albumin-
induced paw edema. The high activity exhibited by Com-
pound F5 could be explained by the number of methoxy
groups on its structure (Fig. 2), which are known to enhance
the anti-inflammatory activity in flavones [25e27]. Compound
F1 showed better anti-inflammatory activity on carrageenan-
induced hind paw edema because there is a glucoseeacid
in its structure. Although the exact nature of the anti-
inflammatory activity of the phytoconstituents has not been
elucidated, the results of this study were validated from a
preclinical point of view; besides, the anti-inflammatory effectpounds on albumin-induced paw edema in rats.
Volume of edema (mL) by hour
1 2 3 4
5 ± 0.18 1.60 ± 0.38 1.95 ± 0.27 1.73 ± 0.34
1 ± 0.12 1.22 ± 0.20* 1.46 ± 0.30** 1.04 ± 0.28**
0 ± 0.38 1.36 ± 0.19 1.62 ± 0.39 1.36 ± 0.23*
9 ± 0.13 1.20 ± 0.31 1.60 ± 0.12* 1.15 ± 0.32**
7 ± 0.18* 1.01 ± 0.22** 1.30 ± 0.14*** 1.03 ± 0.15**
4 ± 0.16* 1.08 ± 0.30* 1.21 ± 0.20*** 1.10 ± 0.12**
3 ± 0.17 1.17 ± 0.16* 1.55 ± 0.26** 1.22 ± 0.20**
7 ± 0.24* 1.03 ± 0.15** 1.08 ± 0.36*** 1.20 ± 0.25**
1 ± 0.22 1.41 ± 0.18 1.51 ± 0.27* 1.19 ± 0.20**
4 ± 0.22 1.42 ± 0.23 1.48 ± 0.33* 1.17 ± 0.21**
Fig. 2 e Chemical structures of Compounds F1eF5.
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 3 8 5e3 9 1390is also supported by its use in folk medicine for treatment of
inflammatory diseases. These studies are valuable for identi-
fying primary compounds that can be used for preparation of
anti-inflammatory drugs, considering the side effects of
NSAIDs and corticosteroids. Furthermore, human studies are
needed to prove the safety and efficacy of long-term admin-
istration of total flavonoids from A. frigida as potential anti-
inflammatory agent in routine clinical practice.
3.4. Conclusions
The total flavonoids from A. frigida caused a significant and
dose-dependent inhibition of increase in paw edema. Results of
HPLC analysis and NMR identification of total flavonoids indi-
cated that there are five flavonoids, namely, 5,3΄-dihydroxy-
3,6,7,4΄-tetramethoxyflavone (F1), 5,7,30-trihydroxy-6,40-dime-
thoxyflavone (F2), 5,30-dihydroxy-6,7,40-trimethoxyflavone (F3),
5-hydroxy-30,40-dimethoxy-7-O-b-D-glucuronide (F4), and
5-hydroxy-30,40,50-trimethoxy-7-O-b-D-glucuronide (F5). Com-
pounds F1eF5 also exhibited a significant suppression of
inflammation in rats when compared with the control. Hence,
thepresenceofflavonesmayplayacontributory role in theanti-
inflammatory activity of total flavonoids isolated fromA. frigida.Conflicts of interest
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